Program estimated to benefit up to 5,000 families per year
HRSA and NMDP Launch New Related Donor Cord Blood Program
MINNEAPOLIS -- October 6, 2008Patients with a medical condition that could be treated by a cord blood transplant may benefit from a new program offered by the U.S. Health Resources and Services Administration (HRSA) and the National Marrow Donor Program (NMDP).
Cord blood offers an additional option to bone marrow in transplant therapy. Through the Related Donor Cord Blood Program, the families of these patients can have the cord blood of a new baby collected and stored at no cost by one of the participating cord blood banks. The cord blood may then be used to treat the affected biological sibling who has the diagnosed disease, which can include leukemia, lymphoma, a sickle-cell disorder, an immune deficiency or a metabolic disease.
“Cord blood collected at the time of birth may offer another treatment option for a sibling diagnosed with various conditions,” said Dr. Jeffrey W. Chell, NMDP chief executive officer. “Physicians nationwide acknowledge that cord blood is a source of the rich, blood-forming cells needed by transplant patients.”
Congress recognized the importance of cord blood by passing the Stem Cell Therapeutic and Research Act in 2005. The Act authorized the Related Donor Cord Blood Program, a three-year demonstration project in which participating and qualified cord blood banks collect and store cord blood at no cost to eligible families.
Patients, families and health care professionals can contact case managers at the NMDP Office of Patient Advocacy to determine eligibility for the program and be referred to a participating cord blood bank. To learn more, call 888-999-6743 or e-mail patientinfo@nmdp.org.
